Emerald Health Therapeutics Announces Completion of Accordion Provision of Pure Sunfarms’ Credit Facility
July 01, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, July 01, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its joint venture for large-scale,...
Emerald Health Therapeutics’ Joint Venture Pure Sunfarms’ Branded Products Ship to Saskatchewan and are Approved in Manitoba
June 24, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, June 24, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its joint venture for large-scale,...
Emerald Health Therapeutics’ Verdélite Launches Souvenir™ Cannabis Brand in Québec
June 23, 2020 06:02 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, June 23, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that its Verdélite Sciences subsidiary in St....
Emerald Health Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
June 19, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, June 19, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and ended March 31,...
Emerald Health Therapeutics to Host 2020 First Quarter Financial Results Conference Call on Friday, June 19, 2020 at 10:30 AM ET
June 11, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, June 11, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that, further to its news release on April...
Emerald Health Therapeutics Closes $2.1 Million Prospectus Sale
June 02, 2020 16:05 ET
|
Emerald Health Therapeutics Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 02, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”)...
Emerald Health Therapeutics Terminates Land Sub-lease and Outdoor Cultivation Agreements
May 27, 2020 19:54 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, May 27, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that it has terminated certain related party...
Emerald Health Therapeutics Announces Pure Sunfarms’ Initial Cultivation and Sales License for Second Greenhouse
May 25, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, May 25, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that its joint venture for large-scale, low-cost,...
Emerald Announces $2.1 Million Prospectus Sale
May 21, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 21, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”)...
Emerald Health Therapeutics Reports Pure Sunfarms First Quarter 2020 Financial Results
May 15, 2020 07:00 ET
|
Emerald Health Therapeutics Inc.
Pure Sunfarms achieves fifth consecutive profitable quarter and 179% quarter-to-quarter growth in retail branded product sales volume; builds on retail success in Ontario with 20% market share in...